David Sussman

600 total citations
25 papers, 440 citations indexed

About

David Sussman is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, David Sussman has authored 25 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Urology, 17 papers in Rheumatology and 6 papers in Epidemiology. Recurrent topics in David Sussman's work include Urinary Bladder and Prostate Research (16 papers), Pelvic floor disorders treatments (15 papers) and Urinary Tract Infections Management (5 papers). David Sussman is often cited by papers focused on Urinary Bladder and Prostate Research (16 papers), Pelvic floor disorders treatments (15 papers) and Urinary Tract Infections Management (5 papers). David Sussman collaborates with scholars based in United States, Canada and Germany. David Sussman's co-authors include Alan D. Garely, Zhonghong Guan, Martin Carlsson, Steven A. Kaplan, Christopher R. Chapple, Dirk De Ridder, Giulio Del Popolo, Peter K. Sand, Victor W. Νitti and Peter Pommerville and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and Urology.

In The Last Decade

David Sussman

24 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sussman United States 10 358 294 169 63 55 25 440
Gerhard Compion United Kingdom 8 455 1.3× 389 1.3× 266 1.6× 81 1.3× 33 0.6× 16 593
J J Wyndaele Belgium 11 463 1.3× 373 1.3× 189 1.1× 58 0.9× 33 0.6× 16 520
H. Kurth France 6 443 1.2× 461 1.6× 292 1.7× 82 1.3× 24 0.4× 8 627
H. Heidler Germany 8 322 0.9× 293 1.0× 155 0.9× 83 1.3× 13 0.2× 21 433
Serge P. Marinkovic United States 12 318 0.9× 368 1.3× 101 0.6× 175 2.8× 40 0.7× 23 472
Stefan G.G. de Wachter Netherlands 14 336 0.9× 281 1.0× 92 0.5× 67 1.1× 51 0.9× 14 373
G. Kiss Austria 11 412 1.2× 342 1.2× 87 0.5× 126 2.0× 66 1.2× 22 513
R. Caremel France 10 200 0.6× 192 0.7× 42 0.2× 101 1.6× 49 0.9× 41 322
Marilena Gubbiotti Italy 13 223 0.6× 171 0.6× 51 0.3× 69 1.1× 92 1.7× 60 399
Gerd Mürtz Germany 13 535 1.5× 444 1.5× 275 1.6× 40 0.6× 11 0.2× 22 578

Countries citing papers authored by David Sussman

Since Specialization
Citations

This map shows the geographic impact of David Sussman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sussman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sussman more than expected).

Fields of papers citing papers by David Sussman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sussman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sussman. The network helps show where David Sussman may publish in the future.

Co-authorship network of co-authors of David Sussman

This figure shows the co-authorship network connecting the top 25 collaborators of David Sussman. A scholar is included among the top collaborators of David Sussman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sussman. David Sussman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaga, Kanya, et al.. (2024). Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan. International Journal of Urology. 31(7). 755–762. 2 indexed citations
2.
Sussman, David, Janneth Pazmino‐Canizares, Hyejung Jung, et al.. (2023). Local Injection for Treating Mood Disorders (LIFT-MOOD): A Pilot Feasibility RCT of Stellate Ganglion Block for Treatment-Resistant Depression. SHILAP Revista de lepidopterología. 7. 2300782075–2300782075. 3 indexed citations
3.
Liu, Helen, David Sussman, Duminda N. Wijeysundera, et al.. (2021). Stellate Ganglion Block for Psychiatric Disorders: A Systematic Review of the Clinical Research Landscape. SHILAP Revista de lepidopterología. 5. 2280676936–2280676936. 16 indexed citations
4.
Sussman, David, Jed Kaminetsky, Mitchell Efros, et al.. (2017). PD26-03 SER120 NASAL SPRAY IS EFFECTIVE IN PATIENTS WITH NOCTURIA IRRESPECTIVE OF ETIOLOGY: A POOLED ANALYSIS OF TWO RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIALS. The Journal of Urology. 197(4S). 1 indexed citations
5.
Νitti, Victor W., David Ginsberg, Karl‐Dietrich Sievert, et al.. (2016). Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. The Journal of Urology. 196(3). 791–800. 80 indexed citations
6.
Robison, Christopher L., et al.. (2016). Barriers to accessing urethroplasty.. PubMed. 18(4). 188–193. 9 indexed citations
7.
Radomski, Sidney B., David Ginsberg, Christopher R. Chapple, et al.. (2015). Clinically Meaningful Improvements in Urinary Incontinence Following Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. Neurourology and Urodynamics. 34.
8.
Everaert, Karel, Heinrich Schulte‐Baukloh, R. Blair Egerdie, et al.. (2015). Impact of onabotulinumtoxinA on quality of life and practical aspects of daily living: A pooled analysis of two randomized controlled trials. International Journal of Urology. 22(12). 1131–1137. 7 indexed citations
9.
Νitti, Victor W., Christopher R. Chapple, David Sussman, et al.. (2014). MP38-01 LONG-TERM EFFICACY AND SAFETY OF REPEAT ONABOTULINUMTOXINA TREATMENT IN OVERACTIVE BLADDER SYNDROME AND URINARY INCONTINENCE: THIRD INTERIM ANALYSIS, MEDIAN 2.4 YEAR FOLLOW-UP. The Journal of Urology. 191(4S). 2 indexed citations
10.
Νitti, Victor W., Karl‐Dietrich Sievert, David Sussman, et al.. (2013). 1367 ONABOTULINUMTOXINA IN PATIENTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE: CONSISTENT EFFECT OVER REPEAT TREATMENT. The Journal of Urology. 189(4S). 4 indexed citations
11.
Sussman, David, Vaishali Patel, Giulio Del Popolo, et al.. (2012). Treatment satisfaction and improvement in health‐related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity. Neurourology and Urodynamics. 32(3). 242–249. 40 indexed citations
12.
Chancellor, Michael B., David Sussman, Giulio Del Popolo, et al.. (2011). Improvement in Health-Related Quality of Life Following Treatment With OnabotulinumtoxinA in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity. 8 indexed citations
13.
Sussman, David, et al.. (2011). Human papillomavirus testing in men.. PubMed. 111(3 Suppl 2). S26–8. 9 indexed citations
14.
Sussman, Gordon L., et al.. (2010). Intermittent allergic rhinitis. Canadian Medical Association Journal. 182(9). 935–937. 4 indexed citations
15.
MacDiarmid, Scott, Pamela Ellsworth, David A. Ginsberg, Michael G. Oefelein, & David Sussman. (2010). Safety and Efficacy of Once-Daily Trospium Chloride Extended-release in Male Patients With Overactive Bladder. Urology. 77(1). 24–29. 7 indexed citations
16.
Sussman, David. (2007). Overactive bladder: treatment options in primary care medicine.. PubMed. 107(9). 379–85. 14 indexed citations
17.
Brown, Gordon & David Sussman. (2004). A current review of medical therapy for benign prostatic hyperplasia.. PubMed. 104(2 Suppl 2). S11–6. 4 indexed citations
18.
Sussman, David & Alan D. Garely. (2002). Treatment of Overactive Bladder with Once-daily Extended-release Tolterodine or Oxybutynin: The Antimuscarinic Clinical Effectiveness Trial (ACET). Current Medical Research and Opinion. 18(4). 177–184. 94 indexed citations
19.
Sussman, David. (2002). Dry mouth is more pronounced in patients with overactive bladder treated with extended release oxybutynin compared to tolterodine. European Urology Supplements. 1(1). 133–133. 2 indexed citations
20.
Kaplan, Steven A., Patricia Gilhooly, Richard F. Labasky, et al.. (2000). Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. Urology. 56(4). 610–616. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerhard Compion Breakdown of academic impact, for papers by J J Wyndaele Breakdown of academic impact, for papers by H. Kurth Breakdown of academic impact, for papers by H. Heidler Breakdown of academic impact, for papers by Serge P. Marinkovic Breakdown of academic impact, for papers by Stefan G.G. de Wachter Breakdown of academic impact, for papers by G. Kiss Breakdown of academic impact, for papers by R. Caremel Breakdown of academic impact, for papers by Marilena Gubbiotti Breakdown of academic impact, for papers by Gerd Mürtz
Rankless by CCL
2026